Influence of serum on the immune recognition of a synthetic lipopeptide mimetic of the 19-kDa lipoprotein from Mycobacterium tuberculosis

Abstract

The innate immune response provides a critical first-line defense against Mycobacterium tuberculosis, an intracellular pathogen that represents a major health threat world-wide. A synthetic lipopeptide (LP) mimicking the lipid moiety of the cell-wall associated 19-kDa lipoprotein from M. tuberculosis has recently been assigned an important role in the induction of an antibacterial immune response in host macrophages. Here, we present experimental data on the biological activities and the biophysical mechanisms underlying cell activation by synthetic 19-kDa M. tuberculosis-derived lipopeptide (Mtb-LP). Investigation of the geometry of the LP (i.e. the molecular conformation and supramolecular aggregate structure) and the preference for membrane intercalation provide an explanation for the biological activities of the mycobacterial LP. Cell activation by low concentrations of Mtb-LP was enhanced by the lipopolysaccharide—binding protein and CD14. However, surprisingly, we found that activation of human macrophages to induce pro- as well as antiinflammatory mediators (tumor necrosis factor(TNF)-α, Interleukin(IL)-6, IL-8, and IL-10) in response to the Mtb-LP is strongly reduced in the presence of serum. This observation could be confirmed for the immune response of murine macrophages which showed a strongly enhanced TNF-α release in the absence of serum, suggesting that the molecular mechanisms of immune recognition of the Mtb-LP are tailored to the ambient conditions of the lung.

Keywords

Monocytes/macrophages cell activation inflammation lipopeptide lung

References

Beutler B. , Rietschel ET Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003; 3: 169-176.

Heine H. , Lien E. Toll-like receptors and their function in innate and adaptive immunity . Int Arch Allergy Immunol 2003; 130: 180-192.

Young DB , Kaufmann SH , Hermans PW , Thole JE Mycobacterial protein antigens: a compilation. Mol Microbiol 1992; 6: 133-145.

Jackett PS , Bothamley GH , Batra HV , Mistry A. , Young DB , Ivanyi J. Specificity of antibodies to immunodominant mycobacterial antigens in pulmonary tuberculosis. J Clin Microbiol 1988; 26: 2313-2318.

Verbon A. , Kuijper S. , Jansen HM , Speelman P. , Kolk AH Antigens in culture supernatant of Mycobacterium tuberculosis: epitopes defined by monoclonal and human antibodies. J Gen Microbiol 1990; 136: 955-964.

Lamb JR , Rees AD , Bal V. et al. Prediction and identification of an HLA-DR-restricted T cell determinant in the 19-kDa protein of Mycobacterium tuberculosis. Eur J Immunol 1988; 18: 973-976.

Faith A. , Moreno C. , Lathigra R. et al. Analysis of human T-cell epitopes in the 19,000 MW antigen of Mycobacterium tuberculosis: influence of HLA-DR. Immunology 1991; 74: 1-7.

Brightbill HD , Libraty DH , Krutzik SR et al. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors . Science 1999; 285: 732-736.

Thoma-Uszynski S. , Stenger S. , Takeuchi O. et al. Induction of direct antimicrobial activity through mammalian Toll-like receptors. Science 2001; 291: 1544-1547.

10.

Noss EH , Pai RK , Sellati TJ et al. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol 2001; 167: 910-918.

11.

Pai RK , Pennini ME , Tobian AA , Canaday DH , Boom WH , Harding CV Prolonged Toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages. Infect Immun 2004; 72: 6603-6614.

12.

Liu PT , Stenger S. , Li H. et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770-1773.

13.

Yeremeev VV , Lyadova IV , Nikonenko BV et al. The 19-kDa antigen and protective immunity in a murine model of tuberculosis. Clin Exp Immunol 2000; 120: 274-279.

14.

Means TK , Lien E. , Yoshimura A. , Wang S. , Golenbock DT , Fenton MJ The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J Immunol 1999; 163: 6748-6755.

15.

Jones BW , Means TK , Heldwein KA et al. Different Toll-like receptor agonists induce distinct macrophage responses. J Leukoc Biol 2001; 69: 1036-1044.

16.

Heldwein KA , Fenton MJ The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect 2002; 4: 937-944.

17.

van Crevel R. , Ottenhoff TH , van der Meer JW Innate immunity to Mycobacterium tuberculosis . Clin Microbiol Rev 2002; 15: 294-309.

18.

Quesniaux V. , Fremond C. , Jacobs M. et al. Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect 2004; 6: 946-959.

19.

Stewart GR , Wilkinson KA , Newton SM et al. Effect of deletion or overexpression of the 19-kilodalton lipoprotein Rv3763 on the innate response to Mycobacterium tuberculosis. Infect Immun 2005; 73: 6831-6837.

20.

Banaiee N. , Kincaid EZ , Buchwald U. , Jacobs Jr WR , Ernst JD Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. J Immunol 2006; 176: 3019-3027.

21.

Ferwerda G. , Girardin SE , Kullberg BJ et al. NOD2 and Toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog 2005; 1: 279-285.

22.

Schromm AB , Howe J. , Ulmer AJ et al. Physicochemical and biological analysis of synthetic bacterial lipopeptides: validity of the concept of endotoxic conformation. J Biol Chem 2007; 282: 11030-11037.

23.

Liu PT , Stenger S. , Tang DH , Modlin RL Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007; 179: 2060-2063.

24.

Metzger JW , Wiesmüller KH , Jung G. Synthesis of N-alpha-Fmoc protected derivatives of S-(2,3-dihydroxypropyl)-cysteine and their application in peptide synthesis. Int J Pept Protein Res 1991; 38: 545-554.

25.

Wiesmüller KH , Bessler WG , Jung G. Solid phase peptide synthesis of lipopeptide vaccines eliciting epitope-specific B-, T-helper and T-killer cell response . Int J Pept Protein Res 1992; 40: 255-260.

26.

Metzger JW , Beck-Sickinger AG , Loleit M. , Eckert M. , Bessler WG , Jung G. Synthetic S-(2,3-dihydroxypropyl)-cysteinyl peptides derived from the N-terminus of the cytochrome subunit of the photoreaction centre of Rhodopseudomonas viridis enhance murine splenocyte proliferation. J Pept Sci 1995; 1: 184-190.

27.

Galanos C. , Lüderitz O. , Westphal O. A new method for the extraction of R lipopolysaccharides. Eur J Biochem 1969; 9: 245-249.

28.

Hirschfeld M. , Ma Y. , Weis JH , Vogel SN , Weis JJ Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J Immunol 2000; 165: 618-622.

29.

Reiling N. , Klug K. , Krallmann-Wenzel U. et al. Complex encounters at the macrophage-mycobacterium interface: studies on the role of the mannose receptor and CD14 in experimental infection models with Mycobacterium avium. Immunobiology 2001 ; 204: 558-571.

30.

Scheel O. , Papavlassopoulos M. , Blunck R. et al. Cell activation by ligands of the Toll-like receptor and interleukin-1 receptor family depends on the function of the large-conductance potassium channel MaxiK in human macrophages. Infect Immun 2006; 74: 4354-4356.

31.

Mueller M. , Brandenburg K. , Dedrick R. , Schromm AB , Seydel U. Phospholipids inhibit lipopolysaccharide (LPS)-induced cell activation: a role for LPS-binding protein. J Immunol 2005 ; 174: 1091-1096.

32.

Schromm AB , Brandenburg K. , Rietschel ET , Flad HD , Carroll SF , Seydel U. Lipopolysaccharide-binding protein mediates CD14-independent intercalation of lipopolysaccharide into phospholipid membranes. FEBS Lett 1996; 399: 267-271.

33.

Roessle MW , Klaering R. , Ristau U. et al. Upgrade of the small-angle X-ray scattering beamline at the European Molecular Biology Laboratory, Hamburg. J Appl Cryst 2007; 40: s190-s194.

34.

Pennini ME , Pai RK , Schultz DC , Boom WH , Harding CV Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling. J Immunol 2006; 176: 4323-4330.

35.

Israelachvili JN Intermolecular and surface forces, 2nd edn. London: Academic Press, 1991; 366-394.

36.

Seydel U. , Wiese A. , Schromm AB , Brandenburg K. A biophysical view on function and activity of endotoxins. In: Brade H , Morrison DC , Opal S , Vogel S. , (eds) Endotoxin in health and diseases. New York: Marcel Dekker , 1998; 195-219.

37.

Schromm AB , Brandenburg K. , Loppnow H. et al. Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur J Biochem 2000; 267: 2008-2013.

38.

Seydel U. , Hawkins L. , Schromm AB et al. The generalized endotoxic principle. Eur J Immunol 2003; 33: 1586-1592.

39.

Gutsmann T. , Schromm AB , Brandenburg K. The physicochemistry of endotoxins in relation to bioactivity. Int J Med Microbiol 2007; 297: 341-352.

40.

Luzzati V. , Vargas R. , Mariani P. , Gulik A. , Delacroix H. Cubic phases of lipid-containing systems. Elements of a theory and biological connotations. J Mol Biol 1993; 229: 540-551.

41.

Gutsmann T. , Müller M. , Carroll SF , MacKenzie RC , Wiese A. , Seydel U. Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPSinduced activation of mononuclear cells. Infect Immun 2001; 69: 6942-6950.

42.

Zweigner J. , Gramm HJ , Singer OC , Wegscheider K. , Schumann RR High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes . Blood 2001; 98: 3800-3808.

43.

Hamann L. , Alexander C. , Stamme C. , Zähringer U. , Schumann RR Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms . Infect Immun 2005; 73: 193-200.

44.

Schröder NW , Opitz B. , Lamping N. et al. Involvement of lipopolysaccharide binding protein, CD14, and Toll-like receptors in the initiation of innate immune responses by treponema glycolipids. J Immunol 2000; 165: 2683-2693.

45.

Weber JR , Freyer D. , Alexander C. et al. Recognition of pneumococcal peptidoglycan: an expanded, pivotal role for LPS binding protein. Immunity 2003 ; 19: 269-279.

46.

Schröder NW , Heine H. , Alexander C. et al. Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J Immunol 2004; 173: 2683-2691.

47.

Goldman RC , Plumley KV , Laughon BE The evolution of extensively drug resistant tuberculosis (XDR-TB): history, status and issues for global control. Infect Disord Drug Targets 2007; 7: 73-91.

48.

Ciaramella A. , Cavone A. , Santucci MB et al. Induction of apoptosis and release of interleukin-1 beta by cell wall-associated 19-kDa lipoprotein during the course of mycobacterial infection. J Infect Dis 2004; 190: 1167-1176.

49.

Biet F. , Bay S. , Thibault VC et al. Lipopentapeptide induces a strong host humoral response and distinguishes Mycobacterium avium subsp. paratuberculosis from M. avium subsp. avium. Vaccine 2008; 26: 257-268.

50.

Poltorak A. , He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-2088.

51.

Shimazu R. , Akashi S. , Ogata H. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999; 189: 1777-1782.

52.

Schromm AB , Lien E. , Henneke P. et al. Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J Exp Med 2001; 194: 79-88.

53.

Melchers F. , Braun V. , Galanos C. The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen. J Exp Med 1975 ; 142: 473-482.

54.

Weis JJ , Ma Y. , Erdile LF Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect Immun 1994; 62: 4632-4636.

55.

Radolf JD , Arndt LL , Akins DR et al. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J Immunol 1995; 154: 2866-2877.

56.

Ozinsky A. , Underhill DM , Fontenot JD et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 2000; 97: 13766-13771.

57.

Gantner BN , Simmons RM , Canavera SJ , Akira S. , Underhill DM Collaborative induction of inflammatory responses by Dectin-1 and Toll-like receptor 2. J Exp Med 2003; 197: 1107-1117.

58.

Viriyakosol S. , Fierer J. , Brown GD , Kirkland TN Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on Toll-like receptor 2 and Dectin-1. Infect Immun 2005 ; 73: 1553-1560.

59.

Yadav M. , Schorey JS The beta-glucan receptor Dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood 2006; 108: 3168-3175.

60.

Buwitt-Beckmann U. , Heine H. , Wiesmüller KH , Jung G. , Brock R. , Ulmer AJ Lipopeptide structure determines TLR2 dependent cell activation level. FEBS J 2005; 272: 6354-6364.

61.

Buwitt-Beckmann U. , Heine H. , Wiesmüller KH et al. Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur J Immunol 2005; 35: 282-289.

62.

Hoebe K. , Georgel P. , Rutschmann S. et al. CD36 is a sensor of diacylglycerides. Nature 2005; 433: 523-527.

63.

Reiling N. , Hölscher C. , Fehrenbach A. et al. Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol 2002; 169: 3480-3484.

64.

Doherty TM , Arditi M.

TB, or not TB: that is the question - does TLR signaling hold the answer?

J Clin Invest 2004; 114: 1699-1703.

65.

Brandenburg K. , Richter W. , Koch Mhj , Meyer HW , Seydel U. Characterization of the nonlamellar cubic and HII structures of lipid A from Salmonella enterica serovar Minnesota by X-ray diffraction and freeze-fracture electron microscopy . Chem Phys Lipids 1998; 91: 53-69.

66.

Wellinghausen N. , Schromm AB , Seydel U. et al. Zinc enhances lipopolysaccharide-induced monokine secretion by alteration of fluidity state of lipopolysaccharide. J Immunol 1996; 157: 3139-3145.

67.

Luhm J. , Schromm AB , Seydel U. et al. Hypothermia enhances the biological activity of lipopolysaccharide by altering its fluidity state. Eur J Biochem 1998; 256: 325-333.

68.

Garidel P. , Rappolt M. , Schromm AB et al. Divalent cations affect chain mobility and aggregate structure of lipopolysaccharide from Salmonella minnesota reflected in a decrease of its biological activity. Biochim Biophys Acta 2005; 1715: 122-131.

69.

Wolf B. , Hauschildt S. , Uhl B. , Metzger J. , Jung G. , Bessler WG Localization of the cell activator lipopeptide in bone marrow-derived macrophages by electron energy loss spectroscopy (EELS). Immunol Lett 1989; 20: 121-126.

70.

Wolf B. , Uhl B. , Hauschildt S. , Metzger J. , Jung G. , Bessler WG Interaction of the lymphoid cell line BCL1 with lipopeptide analogues of bacterial lipoprotein: electron energy loss spectroscopy (EELS) as a novel method to detect the distribution of the activator within the cells. Immunobiology 1989; 180: 93-100.

71.

Uhl B. , Wolf B. , Schwinde A. et al. Intracellular localization of a lipopeptide macrophage activator: immunocytochemical investigations and EELS analysis on ultrathin cryosections of bone marrow-derived macrophages. J Leukoc Biol 1991; 50: 10-18.

72.

Metzger JW , Sawyer WH , Wille B. , Biesert L. , Bessler WG , Jung G. Interaction of immunologically-active lipopeptides with membranes . Biochim Biophys Acta 1993; 1149: 29-39.

73.

Schumann RR , Leong SR , Flaggs GW et al. Structure and function of lipopolysaccharide binding protein. Science 1990; 249: 1429-1431.

74.

Dubin W. , Martin TR , Swoveland P. et al. Asthma and endotoxin: lipopolysaccharide-binding protein and soluble CD14 in bronchoalveolar compartment. Am J Physiol 1996; 270: L736-L744.

75.

Martin TR Recognition of bacterial endotoxin in the lungs. Am J Respir Cell Mol Biol 2000; 23: 128-132.

76.

Neufert C. , Pai RK , Noss EH , Berger M. , Boom WH , Harding CV Mycobacterium tuberculosis 19-kDa lipoprotein promotes neutrophil activation . J Immunol 2001; 167: 1542-1549.

77.

Mueller M. , Stamme C. , Draing C. , Hartung T. , Seydel U. , Schromm AB Cell activation of human macrophages by lipoteichoic acid is strongly attenuated by lipopolysaccharide-binding protein. J Biol Chem 2006; 281: 31448-31456.